Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Azenta Non-GAAP EPS of $0.21 beats by $0.01, revenue of $159M beats by $2.64M; gives FY26 outlook (SeekingAlpha) +++ AZENTA Aktie +4,60%

AZENTA Aktie

 >AZENTA Aktienkurs 
30.2 EUR    +15.3%    (Tradegate)
Ask: 29.8 EUR / 0 Stück
Bid: 29.4 EUR / 0 Stück
Tagesumsatz: 10 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
AZENTA Aktie über LYNX handeln
>AZENTA Performance
1 Woche: -1,5%
1 Monat: -4,1%
3 Monate: +1,6%
6 Monate: +4,0%
1 Jahr: -37,2%
laufendes Jahr: -47,0%
>AZENTA Aktie
Name:  AZENTA INC. DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US1143401024 / 257275
Symbol/ Ticker:  BA3 (Frankfurt) / AZTA (NASDAQ)
Kürzel:  FRA:BA3, ETR:BA3, BA3:GR, NASDAQ:AZTA
Index:  -
Webseite:  https://www.azenta.com/
Profil:  Azenta Inc. is a life sciences company that specia..
>Volltext..
Marktkapitalisierung:  1194.27 Mio. EUR
Unternehmenswert:  966.11 Mio. EUR
Umsatz:  524.82 Mio. EUR
EBITDA:  36.51 Mio. EUR
Nettogewinn:  -96.81 Mio. EUR
Gewinn je Aktie:  -2.11 EUR
Schulden:  45.66 Mio. EUR
Liquide Mittel:  236.29 Mio. EUR
Operativer Cashflow:  72.63 Mio. EUR
Bargeldquote:  1.31
Umsatzwachstum:  -16.48%
Gewinnwachstum:  34.88%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Div. Historie:  02.12.21 - 0.0858€
02.09.21 - 0.0858€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  AZENTA, BROOKS AUTOMATION
Letzte Datenerhebung:  21.11.25
>AZENTA Kennzahlen
Aktien/ Unternehmen:
Aktien: 45.84 Mio. St.
Frei handelbar: 97.96%
Rückkaufquote: 17.73%
Mitarbeiter: 3300
Umsatz/Mitarb.: 0.17 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 9.87%
Bewertung:
KGV: -
KGV lG: 60.68
KUV: 2.22
KBV: 0.84
PEG-Ratio: -
EV/EBITDA: 26.46
Rentabilität:
Bruttomarge: 43.11%
Gewinnmarge: -5.27%
Operative Marge: -4.08%
Managementeffizenz:
Gesamtkaprendite: -1.47%
Eigenkaprendite: -1.74%
>AZENTA Peer Group

Es sind 599 Aktien bekannt.
 
21.11.25 - 12:36
Azenta Non-GAAP EPS of $0.21 beats by $0.01, revenue of $159M beats by $2.64M; gives FY26 outlook (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
21.11.25 - 12:33
Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025 (PR Newswire)
 
Q4'25 reported revenue growth of 6% year over year and 4% on an organic basis FY'25 reported revenue growth of 4% and 3% on an organic basis FY'25 Adjusted EBITDA margin expansion of 310 basis points versus last year FY'26 organic revenue growth expected to be 3% to 5% year over year,......
20.11.25 - 17:51
Azenta FQ4 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.11.25 - 22:06
Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast (PR Newswire)
 
BURLINGTON, Mass., Nov. 12, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2025 earnings which ended on September 30, 2025, on Friday, November 21, 2025, before the market opens. The Company will host a conference call and live webcast......
04.11.25 - 22:09
Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer (PR Newswire)
 
BURLINGTON, Mass., Nov. 4, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership with the PRECEDE Foundation, an international, multi-institutional collaborative focused on early detection and prevention of pancreatic cancer. Azenta will provide secure......
02.10.25 - 23:27
Vergent LMS Appoints Devin Congdon as Senior Systems Administrator (Business Wire)
 
RIDGELAND, Miss.--(BUSINESS WIRE)--#FinancialTechnology--Vergent LMS, a leading provider of loan management solutions, has announced the appointment of Devin Congdon as Senior Systems Administrator. Congdon brings extensive expertise in cloud infrastructure, identity management, and security, with a strong track record of delivering reliable, scalable solutions for the financial services industry. In his new role, Congdon will focus on strengthening Vergent's cloud architecture, ensuring security and reliability across its lending platform. Most recently, he served as Senior Infrastructure & Support Engineer at CIBC Bank US, where he provided support for critical banking applications, optimized performance, and collaborated with developers to resolve code-level issues. Previously, he held senior Azure engineering roles at Spyglass MTG, Azenta Life Sciences, and Trinity Life Sciences, where he designed and implemented secure cloud environments, developed automation strategies, and improved operational eff...
13.09.25 - 01:01
Insiderhandel: President and CEO verkauft Aktien von Azenta im Wert von 9294 USD (Insiderkauf)
 
Marotta, John - Vorstand - Tag der Transaktion: 2025-09-10...
13.08.25 - 00:01
Insiderhandel: EVP, CFO and Treasurer kauft Aktien von Azenta im Wert von 69900 USD (Insiderkauf)
 
Lin, Lawrence Y. - Vorstand - Tag der Transaktion: 2025-08-11...
05.08.25 - 21:18
Azenta reaffirms 3%–5% organic growth and 300bps margin expansion for 2025 as operational turnaround advances (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.25 - 20:36
Azenta (AZTA) Q3 EPS Jumps 36% (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.25 - 12:45
Azenta Non-GAAP EPS of $0.19 beats by $0.05, revenue of $144M misses by $5.81M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.25 - 12:33
Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance (PR Newswire)
 
BURLINGTON, Mass., Aug. 5, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2025. The results of B Medical Systems are treated as discontinued operations and reflected in total diluted EPS, following the Company's......
31.07.25 - 22:09
Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology (PR Newswire)
 
BURLINGTON, Mass., July 31, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered a collaboration with Frenova, a division of Fresenius Medical Care, and Nephronomics, a Renal Precision Medicine company, to begin genomic sequencing and data generation for......
31.07.25 - 14:33
Fresenius Medical Care′s Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care (PR Newswire)
 
Frenova and Nephronomics, a renal precision company co-founded by Fresenius Medical Care, initiate collaboration with GENEWIZ by Azenta Life Sciences Provides vital insights through sophisticated genomic sequencing and analysis of Frenova's My Reason® genomic and clinical data registry......
30.07.25 - 22:07
Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference (PR Newswire)
 
BURLINGTON, Mass., July 30, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference, on Tuesday, August 12, 2025. About Azenta Life Sciences Azenta, Inc. (Nasdaq:......
23.07.25 - 22:06
Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
 
BURLINGTON, Mass., July 23, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2025 earnings which ended on June 30, 2025, on Tuesday August 5, 2025, before the market opens. The Company will host a conference call and live webcast to discuss its financial......
13.05.25 - 22:09
Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development (PR Newswire)
 
Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. BURLINGTON, Mass., May 13, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership between GENEWIZ from Azenta Life......
07.05.25 - 19:51
Azenta targets 3%-5% organic growth and expands automation initiatives for FY2025 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.05.25 - 12:48
Azenta Non-GAAP EPS of $0.05, revenue of $143M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.05.25 - 12:32
Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 (PR Newswire)
 
BURLINGTON, Mass., May 7, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2025. The results of B Medical Systems are treated as discontinued operations and reflected in total diluted EPS, following the Company's......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: In der guten alten Zeit, als der Sex noch schmutzig und die Luft noch sauber war . . . - Dr. Armin Herrmann
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!